NCI | Technology Transfer

HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

Read more about HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

Brazil
BR122021024382-4
Filed on 2021-12-02

ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY

Read more about ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY

US Application 17/532,109
Filed on 2021-11-22

T CELLS MODIFIED TO OVEREXPRESS PHF19

Read more about T CELLS MODIFIED TO OVEREXPRESS PHF19

United Kingdom
18737062.2
Filed on 2019-12-19

T CELLS MODIFIED TO OVEREXPRESS PHF19

Read more about T CELLS MODIFIED TO OVEREXPRESS PHF19

France
18737062.2
Filed on 2019-12-19

T CELLS MODIFIED TO OVEREXPRESS PHF19

Read more about T CELLS MODIFIED TO OVEREXPRESS PHF19

Germany
18737062.2
Filed on 2019-12-19

ANTIVIRAL STRUCTURALLY-STABILIZED EBOLAVIRUS PEPTIDES AND USES THEREOF

Read more about ANTIVIRAL STRUCTURALLY-STABILIZED EBOLAVIRUS PEPTIDES AND USES THEREOF

Patent Cooperation Treaty
PCT/US2021/058023
Filed on 2021-11-04

MODIFIED CELLS AND METHODS OF THERAPY

Read more about MODIFIED CELLS AND METHODS OF THERAPY

Japan
2021-149724
Filed on 2021-09-14

ANTI-MUTATED KRAS T CELL RECEPTORS

Read more about ANTI-MUTATED KRAS T CELL RECEPTORS

US Patent 12,312,391
Filed on 2021-11-24

METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT

Read more about METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT

European Patent
21217161.5
Filed on 2021-12-22

Delivery Of Packaged RNA To Mammalian Cells

Read more about Delivery Of Packaged RNA To Mammalian Cells

Australia
2021240286
Filed on 2021-10-01

Subscribe to NCI